Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 7, 2003, Pages 1299-1310

  Petzer, Jacobus P ^a   Steyn, Salome ^a   Castagnoli, Kay P ^a   Chen, Jiang Fan ^b   Schwarzschild, Michael A ^b   Van Der Schyf, Cornelis J ^a,c   Castagnoli, Neal ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR ANTAGONIST; AMINE OXIDASE (FLAVIN CONTAINING); ISTRADEFYLLINE;

ARTICLE; CHEMICAL STRUCTURE; DRUG ACTIVITY; DRUG POTENCY; DRUG TARGETING; ENZYME INHIBITION; IN VITRO STUDY; MOTOR PERFORMANCE; NEUROPROTECTION; NEUROTOXICITY; PARKINSON DISEASE;

GYMNOMYZA SAMOENSIS;

EID: 0037375621     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00648-X     Document Type: Article

References (49)

1. Marsden, C. D.; Perkes, J. D.; Quinn, N. In Movements Disorders; Marsden, C. D., Fahn, S., Eds; Butterworth Scientific: NY, USA, 1982; p. 96.
2. Koller W.C., Hubble J.P. Neurology. 40(Suppl. 3):1990;40.
3. Koller W.C. Exp. Neurol. 144:1997;24.
4. Jackson-Lewis V., Jokowec M., Burke R.E., Przedborski S. Neurodegeneration. 4:1995;257.
5. Markey S.P., Johannessen J.N., Chiueh C.C., Burns R.S., Herkenham M.A. Nature. 31:1984;464.
6. Nicklas W.J., Vyas I., Heikkila R.E. Life Sci. 36:1985;2503.
7. Ramsay R.R., Krueger M.J., Youngster S.K., Gluck M.R., Casuda J.E., Singer T.P. J. Neurochem. 56:1991;1184.
8. Chiba K., Trevor A.J., Castagnoli N. Jr. Biochem. Biophys. Res. Commun. 120:1984;574.
9. Chiba K., Peterson L.A., Castagnoli K.P., Trevor A.J., Castagnoli N. Jr. Drug Metab. Dispos. 13:1985;342.
10. Heikkila R.E., Manzino L., Cabbat F.S., Duvoison R.C. Nature. 311:1984;467.
11. Castagnoli K., Palmer S., Anderson A., Bueters T., Castagnoli N. Jr. Chem. Res. Toxicol. 10:1997;364.
12. Castagnoli K.P., Steyn S.J., Petzer J.P., Van der Schyf C.J., Castagnoli N. Jr. Chem. Res. Toxicol. 14:2001;523.
13. Di Monte D.A., Royland J.E., Anderson A., Castagnoli K., Castagnoli N. Jr., Langston J.W. J. Neurochem. 69:1997;1771.
14. Kupsch A., Sautter J., Gotz M.E., Breithaupt W., Schwarz J., Youdim M.B., Riederer P., Gerlach M., Oertel W.H. J. Neural. Transm. 108:2001;985.
15. Tatton W.G., Greenwood C.E. J. Neurosci. Res. 30:1991;666.
16. Tatton W.G. Mov. Disord. 8:1993;20.
17. Wu R.M., Chieuh C.C., Pert A., Murphy D.L. Eur. J. Pharm. 243:1993;241.
18. Kanda T., Jackson M.J., Smith L.A., Pearce R.K.B., Nakamura J., Kase H., Kuwana Y., Jenner P. Exper. Neurol. 162:2000;321.
19. Grondin R., Bedard P.J., Tahar A.H., Gregoire L., Mori A., Kase H. Neurology. 52:1999;1673.
20. Shiozaki S., Ichikawa S., Nakamura J., Kitamura S., Yamada K., Kuwana Y. Psychopharmacology. 147:1999;90.
21. Ikeda K., Kurokawa M., Aoyama S., Kuwana Y. J. Neurochem. 80:2002;262.
22. Chen J.-F., Xu K., Petzer J.P., Staal R., Xu Y.-H., Beilstein M., Sonsalla P.K., Castagnoli K., Castagnoli N. Jr., Schwarzschild M.A. J. Neurosci. 21:2001;143.
23. Jacobson K.A., Gallo-Rodriguez C., Melman N., Fischer B., Maillard M., Van Bergen A., Van Galen P.J.M., Karton Y. J. Med. Chem. 36:1993;1333.
24. Müller C.E., Geis U., Hipp J., Schobert U., Frobenius W., Pawlowski M., Suzuki F., Sandoval-Ramirez J. J. Med. Chem. 40:1997;4396.
25. Chen J.-F., Steyn S., Staal R., Petzer J.P., Xu K., Van der Schyf C.J., Castagnoli K., Sonsalla P.K., Castagnoli N. Jr., Schwarzschild M.A. J. Biol. Chem. 277:2002;36040.
26. Blicke F.F., Godt H.C. Jr. J. Am. Chem. Soc. 76:1954;2798.
27. Suzuki F., Shimada J., Shiozaki S., Ichikawa S., Ishii A., Nakamura J., Nonaka H., Kobayashi H., Fuse E. J. Med. Chem. 36:1993;2508.
28. Nonaka Y., Shimada J., Nonaka H., Koike N., Aoki N., Kobayashi H., Kase H., Yamaguchi K., Fumio S. J. Med. Chem. 36:1993;3731.
29. Philip J., Szulczewski D.H. J. Pharm. Sci. 62:1973;1885.
30. Shimada J., Koike N., Nonaka H., Shiozaki S., Yanagawa K., Kanada T., Kobayashi H., Fumio S. Bioorg. Med. Chem. Lett. 7:1997;2349.
31. Phillips, M. A. J. Chem. Soc. Part 2, 1928, 2393.
32. Dubey P.K., Eswara Rao D., Ramanatham J., Kumar R., Grossert J.S. J. Indian. Chem. Soc. 75:1998;460.
33. Nimkar S.K., Anderson A., Rimoldi J.M., Stanton J.M., Castagnoli K.P., Mabic S., Wang Y.-X., Castagnoli N. Jr. Chem. Res. Toxicol. 9:1996;1013.
34. Inoue H., Castagnoli K., Van der Schyf C., Mabic S., Igarashi K., Castagnoli N. Jr. J. Pharmacol. Exp. Ther. 291:1999;856.
35. Heikkila R.E., Hess A., Duvoisin R.C. Science. 224:1984;1451.
36. Sedelis M., Schwarting R.K., Huston J. Behav. Brain. Res. 125:2001;109.
37. Suzuki, F.; Shimada, J.; Koike, N.; Nakamura, J.; Shioazaki, S.; Ichikawa, S.; Ishii, A.; Nonaka, H. United States Patent, Jan 16 1996. PN/5,484,920.
38. Gnerre C., Catto M., Leonetti F., Weber P., Carrupt P.-A., Altomare C., Carotti A., Testa B. J. Med. Chem. 43:2000;4747.
39. Harfenist B., Heuser D.J., Joyner C.T., Batchelor J.F., White H.L. J. Med. Chem. 39:1996;1857.
40. Kneubuehler S., Thull U., Altomare C., Carta V., Gaillard P., Carrupt P.-A., Carotti A., Testa B. J. Med. Chem. 38:1995;3974.
41. Segel I.H. Enzyme Kinetics. 1993;Wiley, New York. p. 100.
42. Binda C., Newton-Vinson P., Hubalec F., Edmondson D.E., Mattevi A. Nat. Struct. Biol. 9:2002;22.
43. Pitts, S. M.; Markey, S. P.; Murphy, D. L.; Weisz, A. In MPTP: A Neurotoxin Producing a Parkinsonian Syndrome; Markey, S.P., Castagnoli, N. Jr., Trevor, A. J., Kopin, I. J., Eds.; Academic: New York, 1986; p. 703.
44. Schmidle C.J., Mansfield R.C. J. Am. Chem. Soc. 78:1956;425.
45. Hall L., Murray S., Castagnoli K., Castagnoli N. Jr. Chem. Res. Toxicol. 5:1992;625.
46. Popov I.I. Chem. Heterocyc. Comp. 33:1997;949.
47. Salach J., Weyler J. Methods Enzymol. 142:1987;627.
48. Bradford M.M. Anal. Biochem. 72:1976;247.
49. Khalil A.A., Steyn S., Castagnoli N. Jr. Chem. Res. Toxicol. 13:2000;31.